CWM
MRVI icon

CIBC World Markets’s Maravai LifeSciences MRVI Stock Holding History

CIBC World Markets’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$36.2K Sell
15,040
-9,468
-39% -$19.9K ﹤0.01% 1498
2025
Q1 		$54.2K Buy
24,508
+14,172
+137% +$56K ﹤0.01% 1707
2024
Q4 		$56.3K Buy
+10,336
New +$66.5K ﹤0.01% 1254
2024
Q2 		– Sell
-45,736
Closed -$397K – 765
2024
Q1 		$397K Buy
+45,736
New +$309K ﹤0.01% 749

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CIBC World Markets's MRVI Position: Q2 2025 in Review

CIBC World Markets reduced its Maravai LifeSciences (MRVI) stake by 39% in Q2 2025, selling an estimated $19.9K and leaving 15,040 shares worth $36.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1498.

CIBC World Markets first reported a position in MRVI in Q1 2024 and has held it in 4 quarters since. The position peaked at $397K in Q1 2024. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • CIBC World Markets held 15,040 shares of Maravai LifeSciences worth $36.2K as of Q2 2025.
  • CIBC World Markets sold 9,468 Maravai LifeSciences shares in Q2 2025, an estimated $19.9K.
  • Maravai LifeSciences made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1498 holding.
  • CIBC World Markets first reported a position in Maravai LifeSciences in Q1 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Maravai LifeSciences position peaked at $397K in Q1 2024.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.